UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): August 14, 2002
STERICYCLE, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-21229 36-3640402
(State or other juris- (Commission file (IRS employer
diction of incorporation) number) identification number)
28161 North Keith Drive
Lake Forest, Illinois 60045
(Address of principal executive offices)
Registrant's telephone number, including area code:
(847) 367-5910
Item 5. Other Events
On August 14, 2002, Stericycle, Inc. (the "Company"), acting in response to
inaccurate rumors that had recently come to its attention, announced that it had
reached an agreement in principle to settle an antitrust investigation by the
Arizona Attorney General's office relating to Company's December 1997 sale and
purchase of medical waste assets in Utah and Arizona with Browning-Ferris
Industries, Inc. ("BFI") and the Company's subsequent failure to provide
treatment services to certain third-party haulers of medical waste at the
Company's treatment facilities in Arizona and Utah.
The Company also confirmed that it is currently in settlement discussions
with the Utah Attorney General's office in connection with an antitrust
investigation related to the same issues.
A copy of the Company's press release is filed as an exhibit to this
Report.
Item 7. Financial Statements and Exhibits
The following exhibit is filed with this Report:
Exhibit Description
------- -----------
99.1 Press Release dated August 14, 2002
- 2 -
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: August 22, 2002.
Stericycle, Inc.
By /s/ Frank J.M. ten Brink
---------------------------------------
Frank J.M. ten Brink
Executive Vice President and
Chief Financial Officer
- 3 -